Search research articles
Contact Us
Filters
Showing results (31-40 of 215) with videos related to
Page
of 22
Sort By:
International Journal of Molecular Sciences
|
September 21, 2017
Mouse Monoclonal Antibodies Generated from Full Length Human Cereblon: Detection of Cereblon Protein in Patients with Multiple Myeloma
Xiubao Chang, Qinqin Xu, Yuexian Hou, et al.
Leukemia Research
|
August 23, 2005
Analysis of PTEN deletions and mutations in multiple myeloma
Hong Chang, Xiao Ying Qi, Jaime Claudio, et al.
Leukemia & Lymphoma
|
August 5, 2004
Detection of chromosome 13q deletions and IgH translocations in patients with multiple myeloma by FISH: comparison with karyotype analysis
Hong Chang, Dan Li, Lihua Zhuang, et al.
Blood
|
March 3, 2007
Preclinical studies of the pan-Bcl inhibitor obatoclax (GX015-070) in multiple myeloma
Suzanne Trudel, Zhi Hua Li, Jennifer Rauw, et al.
Blood
|
March 12, 2005
Immunohistochemistry accurately predicts FGFR3 aberrant expression and t(4;14) in multiple myeloma
Hong Chang, A Keith Stewart, Xiao Ying Qi, et al.
Leukemia
|
April 23, 2004
Analysis of IgH translocations, chromosome 13q14 and 17p13.1(p53) deletions by fluorescence in situ hybridization in Waldenstrom's macroglobulinemia: a single center study of 22 cases
H Chang, S Samiee, D Li, et al.
British Journal of Haematology
|
September 26, 2015
A Phase Ib Study of the combination of the Aurora Kinase Inhibitor Alisertib (MLN8237) and Bortezomib in Relapsed Multiple Myeloma
Allison Rosenthal, Shaji Kumar, Craig Hofmeister, et al.
Haematologica
|
May 16, 2015
Proteasome inhibitors block Ikaros degradation by lenalidomide in multiple myeloma
Chang-Xin Shi, Klaus Martin Kortüm, Yuan Xiao Zhu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 2005
Clinical outcomes in t(4;14) multiple myeloma: a chemotherapy-sensitive disease characterized by rapid relapse and alkylating agent resistance
Wilfrid Jaksic, Suzanne Trudel, Hong Chang, et al.
Blood
|
July 10, 2015
Melphalan, prednisone, and thalidomide vs melphalan, prednisone, and lenalidomide (ECOG E1A06) in untreated multiple myeloma
A Keith Stewart, Susanna Jacobus, Rafael Fonseca, et al.
Page
of 22
Search research articles
Search
Showing results (31-40 of 215) with videos related to
Sort By:
Page
of 22
International Journal of Molecular Sciences
|
September 21, 2017
Mouse Monoclonal Antibodies Generated from Full Length Human Cereblon: Detection of Cereblon Protein in Patients with Multiple Myeloma
Xiubao Chang, Qinqin Xu, Yuexian Hou, et al.
Leukemia Research
|
August 23, 2005
Analysis of PTEN deletions and mutations in multiple myeloma
Hong Chang, Xiao Ying Qi, Jaime Claudio, et al.
Leukemia & Lymphoma
|
August 5, 2004
Detection of chromosome 13q deletions and IgH translocations in patients with multiple myeloma by FISH: comparison with karyotype analysis
Hong Chang, Dan Li, Lihua Zhuang, et al.
Blood
|
March 3, 2007
Preclinical studies of the pan-Bcl inhibitor obatoclax (GX015-070) in multiple myeloma
Suzanne Trudel, Zhi Hua Li, Jennifer Rauw, et al.
Blood
|
March 12, 2005
Immunohistochemistry accurately predicts FGFR3 aberrant expression and t(4;14) in multiple myeloma
Hong Chang, A Keith Stewart, Xiao Ying Qi, et al.
Leukemia
|
April 23, 2004
Analysis of IgH translocations, chromosome 13q14 and 17p13.1(p53) deletions by fluorescence in situ hybridization in Waldenstrom's macroglobulinemia: a single center study of 22 cases
H Chang, S Samiee, D Li, et al.
British Journal of Haematology
|
September 26, 2015
A Phase Ib Study of the combination of the Aurora Kinase Inhibitor Alisertib (MLN8237) and Bortezomib in Relapsed Multiple Myeloma
Allison Rosenthal, Shaji Kumar, Craig Hofmeister, et al.
Haematologica
|
May 16, 2015
Proteasome inhibitors block Ikaros degradation by lenalidomide in multiple myeloma
Chang-Xin Shi, Klaus Martin Kortüm, Yuan Xiao Zhu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 2005
Clinical outcomes in t(4;14) multiple myeloma: a chemotherapy-sensitive disease characterized by rapid relapse and alkylating agent resistance
Wilfrid Jaksic, Suzanne Trudel, Hong Chang, et al.
Blood
|
July 10, 2015
Melphalan, prednisone, and thalidomide vs melphalan, prednisone, and lenalidomide (ECOG E1A06) in untreated multiple myeloma
A Keith Stewart, Susanna Jacobus, Rafael Fonseca, et al.
Page
of 22